Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5642708 | Oral Oncology | 2017 | 10 Pages |
Abstract
Firstly, DCLK1 is a prognostic biomarker for shortened survival. Secondly, through inhibition of DCLK1, it may serve as a therapeutic target as well.
Keywords
CSCDCLK1OPSCCLSCCOSCCDFSHNSCCDMSOdisease-free survivaloverall survivalDimethyl sulfoxideRadiotherapyHead and neckCancer stem cellsHuman papilloma virusHPVSquamous cell carcinomaOropharyngeal squamous cell carcinomalaryngeal squamous cell carcinomaoral squamous cell carcinomaHead and neck squamous cell carcinomadoublecortin-like kinase 1
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Lorenz Kadletz, Dietmar Thurnher, Robert Wiebringhaus, Boban M. Erovic, Ulana Kotowski, Sven Schneider, Rainer Schmid, Lukas Kenner, Gregor Heiduschka,